Allotex

Allotex tissue addition symposium 2024: Episode 4/4 Dr Francesco Carones gives invaluable insights into the implementation of Allotex solutions in your clinic. Link to the full video here: https://lnkd.in/gFa7sDmw #Allotex

Big day for myself and our clinics. We constantly improve our skills, widen treatment options for our patients. From today we offer new option to treat presbyopia with tissue addition Technology #allotex Looking forward for this exciting journey! Another option for our Life Vision Journey Concept!

?? What is Allotex? At Allotex, we’re revolutionizing vision correction. As a pioneer in ophthalmic biologics, we offer advanced, patient-centric tissue addition technologies for presbyopia. Our innovative bioidentical corneal inlays are designed to restore youthful vision. Our groundbreaking approach leverages precisely shaped human corneal allografts, providing patients with a personalized, minimally invasive alternative to traditional treatments. Discover the future of vision correction—where innovation meets biology. ?? Learn more at eu.allotex.com #VisionRevolution #Allotex #EyeHealth #Biologics #Presbyopia #Ophthalmology?#Innovation #EyeSurgery #RefractiveSurgery

Allotex tissue addition symposium 2024: Episode 3/4 Mr Brendan Cummings shares his experience on how to get started with Allotex. Link to the full video here: https://lnkd.in/gBxUJ7qm #Allotex

???? Introducing Prof. Michael Mrochen: A Leader in Ophthalmic Innovation With nearly 30 years of experience in the ophthalmic industry, Prof. Michael Mrochen has consistently driven groundbreaking advancements that have reshaped vision care. As the Co-Founder of Allotex, Prof. Mrochen combines his extensive technical expertise, clinical insight, and entrepreneurial leadership to develop innovative solutions for vision correction. Prof. Mrochen holds a background in physics engineering and a doctorate in theoretical medicine, and has been instrumental in the development and commercialization of cutting-edge ophthalmic technologies. His contributions bridge the gap between technical precision and clinical success, leading to meaningful advancements in vision correction and eye care. His vast network, spanning technical, clinical, and commercial sectors, enables him to connect the various facets of innovation in ways few can. As a result, Prof. Mrochen's work has made a lasting impact on the industry, improving the quality of life for millions of patients worldwide. #OphthalmologyLeader #MichaelMrochen #VisionCareInnovation #Allotex #VisionCorrection #EyeCareTechnology #HealthcareInnovation #TechInHealth #LeadershipInScience

Allotex tissue addition symposium 2024: Episode 2/4 Dr Aylin K?l?? outlines the outcomes of our clinical study. Link to the full video here: https://lnkd.in/ggqDUEei #Allotex

Allotex tissue addition symposium 2024: Episode 2/4 Dr Aylin K?l?? outlines the outcomes of our clinical study. Link to the full video here: https://lnkd.in/ggqDUEei #Allotex

?? A Century of Progress in Corneal Tissue Use For nearly 100 years, corneal tissue has been a foundational element in vision correction procedures, with continuous advancements in both precision and efficacy. At Allotex, we are building on this rich history with our cutting-edge tissue addition technology, offering a transformative solution for permanent, natural vision correction. ??? By leveraging nearly a century of innovation, we are driving the next generation of ophthalmic care and shaping the future of eye health. ?? #VisionCorrection #Ophthalmology #TissueAdditionTechnology #Allotex #EyeCareInnovation #FutureOfVision #HealthcareInnovation Not for sale in the US.

Allotex tissue addition symposium 2024: Episode 1/4 David Muller, CEO of Allotex, talks about the idea behind Allotex and its technology. Link to the full video here: https://lnkd.in/g_YNj25Q #Allotex

???? Introducing Dr. David Muller: A Visionary Leader in Ophthalmology With a distinguished career dedicated to advancing the field of ophthalmology, Dr. David Muller is a pioneering figure in vision correction. As the CEO and founder of Allotex, Dr. Muller continues to drive innovation with cutting-edge solutions. Before establishing Allotex, Dr. Muller founded Avedro, Inc., where he recognized the transformative potential of corneal cross-linking. Under his leadership, Avedro achieved FDA approval in 2016, making this crucial treatment widely accessible to patients suffering from keratoconus, a sight-threatening condition. Earlier in his career, Dr. Muller played a pivotal role in the development of laser vision correction as the founder and CEO of Summit Technology, leading the company to obtain FDA approval for the first laser vision correction procedure, improving vision for millions globally. Dr. Muller's academic background includes a BA from Boston University, a doctorate in physical chemistry from Cornell University, and an MBA from The Wharton School. His unique combination of scientific expertise and business leadership has solidified his status as a key influencer in the ophthalmology sector. #LeadershipInVisionCare #DavidMuller #Ophthalmology #CornealCrossLinking #LaserVisionCorrection #Allotex #InnovationInEyeCare #VisionCorrection #HealthcareLeadership #TechInHealth